Jane E. Cavanaugh, Associate Professor of Pharmacology; Ph.D. Mechanisms of cell death and survival in the diseased (Parkinson’s disease, Alzheimer’s disease) and nondiseased (normal aging) brain.
David A. Johnson, Associate Professor of Pharmacology-Toxicology; Ph.D. Drugs which enhance the function of neuronal pathways involved with learning and memory, neuro-pathology and the treatment of eating disorders.
Rehana K. Leak, Associate Professor of Pharmacology; Ph.D. Understanding how cells adapt to low levels of stressors, a capacity that may be reduced in individuals genetically predisposed to neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Lauren O'Donnell, Associate Professor of Pharmacology; Ph.D. Viral infections of the central nervous system, Impact of inflammation and infection on the developing brain and Protective strategies against neuroinflammation.
Christopher K. Surratt, Professor of Pharmacology; Ph.D. Structure-function studies on brain receptors that recognize psychostimulant and opiate drugs of abuse.
Paula A. Witt-Enderby, Professor of Pharmacology and Toxicology; Ph.D. Molecular pharmacology of melatonin receptors and its associated signaling cascades with emphasis on the role melatonin in stem cell differentiation.